ecyt_Current Folio_DEFA14A



Washington, D.C. 20549


Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.  )





Filed by the Registrant 


Filed by a Party other than the Registrant 


Check the appropriate box:



Preliminary Proxy Statement





Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2))





Definitive Proxy Statement





Definitive Additional Materials





Soliciting Material under §240.14a‑12








Endocyte, Inc.

(Name of Registrant as Specified In Its Charter)


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check the appropriate box):



No fee required.





Fee computed on table below per Exchange Act Rules 14a‑6(i)(1) and 0‑11.







Title of each class of securities to which transaction applies:








Aggregate number of securities to which transaction applies:








Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (set forth the amount on which the filing fee is calculated and state how it was determined):








Proposed maximum aggregate value of transaction:








Total fee paid:






Fee paid previously with preliminary materials.





Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.





Amount Previously Paid:






Form, Schedule or Registration Statement No.:






Filing Party:






Date Filed:








ENDOCYTE INC_Notice Card_endocyte inc_notice card_page_1.gif





ENDOCYTE INC_Notice Card_endocyte inc_notice card_page_2.gif

*** Exercise Your Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on May 3, 2018. ENDOCYTE, INC. You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of ENDOCYTE, INC. 8910 PURDUE ROAD SUITE 250 INDIANAPOLIS, IN 46268 the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting. proxy materials and voting instructions. E40577-P03060 See the reverse side of this notice to obtain Meeting Information Meeting Type:Annual Meeting For holders as of:March 9, 2018 Date: May 3, 2018Time: 12:00 PM EDT Location: Offices of Faegre Baker Daniels LLP 600 East 96th Street Suite 600 Indianapolis, Indiana 46240 For directions to the meeting, please call: 317-569-9600



ENDOCYTE INC_Notice Card_endocyte inc_notice card_page_3.gif

Before You Vote How to Access the Proxy Materials Have the information that is printed in the box marked by the arrow XXXX XXXX XXXX XXXX (located on the by the arrow XXXX XXXX XXXX XXXX (located on the following page) in the subject line. How To Vote Please Choose One of the Following Voting Methods marked by the arrow XXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions. E40578-P03060 Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Vote By Internet: To vote now by Internet, go to Have the information that is printed in the box Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card. Proxy Materials Available to VIEW or RECEIVE: NOTICE AND PROXY STATEMENTANNUAL REPORT/FORM 10-K WRAP How to View Online: following page) and visit: www.proxyvote .com. How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: 1) BY 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL* * If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 19, 2018 to facilitate timely delivery.






ENDOCYTE INC_Notice Card_endocyte inc_notice card_page_4.gif

The Board of Directors recommends you vote FOR the following: 1. Election of Directors 1a. Patrick Machado 1b. Dr. Lesley Russell 1c. Dawn Svoronos The Board of Directors recommends you vote FOR the following proposals: 2. Ratify the appointment of Ernst & Young LLP as our independent Registered Public Accounting Firm for 2018. 3. Advisory proposal approving the compensation of our Named Executive Officers ("Say-on-Pay"). NOTE: At their discretion, the proxies are authorized to vote on any other business brought before the meeting or any adjournment thereof. E40579-P03060 Voting Items